Provides Tetra with stable supply of high-quality ingredients and regulatory-approved services to satisfy clinical trials and prescription products Diversifies Akanda into cancer pain medical market as a specialized manufacturer of cannabis-based drugs for use in FDA clinical trials and pharmaceutical markets LONDON & MONTREAL–(BUSINESS WIRE)–Akanda Corp. (“Akanda”) (NASDAQ: AKAN)... Read more